Stephan Kemmner
Overview
Explore the profile of Stephan Kemmner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
321
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bachmann Q, Torrez C, Buttner-Herold M, Haller B, Haberfellner F, Hausinger R, et al.
Transpl Int
. 2025 Jan;
37():13646.
PMID: 39834691
Here, we retrospectively evaluated the informational yield of 338 post-reperfusion kidney transplant biopsies (including 95 living donations) assessed according to BANFF for the histological characteristics interstitial fibrosis and tubular atrophy...
2.
Ziemann M, Lindemann M, Hallensleben M, Altermann W, Althaus K, Budde K, et al.
Transplant Direct
. 2024 Aug;
10(9):e1680.
PMID: 39131238
Background: Preformed donor-specific HLA antibodies (DSA) are a well-known risk factor in kidney transplantation. There is still considerable debate, however, about the optimal risk stratification among patients with preformed DSA....
3.
Fuessl L, Kreuzer L, Nierychlewski K, Seibt T, Stangl M, Koliogiannis D, et al.
Front Med (Lausanne)
. 2024 Jul;
11:1336035.
PMID: 38988355
The calcineurin inhibitor tacrolimus, which is available as an immediate- or extended-release formulation, is the standard-of-care immunosuppression after kidney transplantation with low rejection rates, especially in the first year after...
4.
Seibt T, Wahida A, Hoeft K, Kemmner S, Linkermann A, Mishima E, et al.
Nephrol Dial Transplant
. 2024 Apr;
39(11):1754-1761.
PMID: 38684468
Ferroptosis is a regulated cell death modality triggered by iron-dependent lipid peroxidation. Ferroptosis plays a causal role in the pathophysiology of various diseases, making it a promising therapeutic target. Unlike...
5.
Wahida A, Schmaderer C, Buttner-Herold M, Branca C, Donakonda S, Haberfellner F, et al.
iScience
. 2023 Oct;
26(10):107879.
PMID: 37868627
Renal ischemia-reperfusion injury (IRI) is associated with reduced allograft survival, and each additional hour of cold ischemia time increases the risk of graft failure and mortality following renal transplantation. Receptor-interacting...
6.
Shen Y, Schmaderer C, Ossadnik A, Hammitzsch A, Carbajo-Lozoya J, Bachmann Q, et al.
Int J Nephrol
. 2023 Oct;
2023:7772677.
PMID: 37809041
Introduction: Due to chronic inflammation, maintenance hemodialysis (MHD) patients continue to show excess mortality. Acetate-free citrate-buffered A concentrates could be a way to improve the biocompatibility of the procedure, reduce...
7.
Schaier M, Morath C, Wang L, Kleist C, Opelz G, Tran T, et al.
Front Immunol
. 2023 Jul;
14:1089664.
PMID: 37483623
Background: The administration of modified immune cells (MIC) before kidney transplantation led to specific immunosuppression against the allogeneic donor and a significant increase in regulatory B lymphocytes. We wondered how...
8.
Grigorescu M, Kemmner S, Schonermarck U, Sajin I, Guenther W, Cerqueira T, et al.
Front Med (Lausanne)
. 2022 Dec;
9:1004413.
PMID: 36465930
[This corrects the article DOI: 10.3389/fmed.2022.904795.].
9.
Morath C, Schmitt A, Schmitt M, Wang L, Kleist C, Opelz G, et al.
BMJ Open
. 2022 Nov;
12(11):e066128.
PMID: 36368749
Introduction: Donor-derived modified immune cells (MIC) induced long-term specific immunosuppression against the allogeneic donor in preclinical models of transplantation. In a phase I clinical trial (TOL-1 Study), MIC treatment resulted...
10.
Grigorescu M, Kemmner S, Schonermarck U, Sajin I, Guenther W, Cerqueira T, et al.
Front Med (Lausanne)
. 2022 Jun;
9:904795.
PMID: 35755074
Background: Kidney transplantation is the best treatment option for patients with end-stage kidney disease (ESKD) with a superiority of graft survival after living kidney donation (LKD) compared to deceased donation....